Moomoo AI 已提取核心信息
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Cingulate Inc.（CING）执行副总裁兼首席医学官马修·布拉姆斯于2024年4月3日参与了一笔交易。公告中未披露交易的具体细节，例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。这些信息对于投资者了解其投资的潜在影响以及内部人士对公司前景的信心至关重要。
Cingulate Inc.（CING）执行副总裁兼首席医学官马修·布拉姆斯于2024年4月3日参与了一笔交易。公告中未披露交易的具体细节，例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。这些信息对于投资者了解其投资的潜在影响以及内部人士对公司前景的信心至关重要。
有用
没用
该公告为独立文件：